Strategies for Enhancing Inflammatory Bowel Disease Care in Pakistan: Bridging Gaps and Building Capacities
- PMID: 38720936
- PMCID: PMC11078041
- DOI: 10.1093/crocol/otae027
Strategies for Enhancing Inflammatory Bowel Disease Care in Pakistan: Bridging Gaps and Building Capacities
Conflict of interest statement
JD: Lawrence C. Pakula, MD IBD Education Fund at Washington University in Saint Louis, St. Louis, MO, USA. ASB declare no conflicts of interest. PD: has received research support under a sponsored research agreement unrelated to the data in the paper and/or consulting from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Pfizer, Prometheus Biosciences, Takeda Pharmaceuticals, Roche Genentech, Scipher Medicine, Fresenius Kabi, Teva Pharmaceuticals, Landos Pharmaceuticals, Iterative scopes and CorEvitas, LLC. PD receive research support from an Investigator-Initiated Study from Takeda Pharmaceuticals.
Figures
Comment in
References
-
- Population WA. Worldometer Asia population [March 16, 2024]. https://www.worldometers.info/
-
- Chang AY, Cowling K, Micah AE, et al.Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. Lancet. 2019;393(10187):2233-2260. doi: 10.1016/S0140-6736(19)30841-4 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources